Researchers at the Lawrence Berkeley National Laboratory have developed a design and training framework ...

The deal could be worth more than $1 billion, if all genetic targets identified lead to approved therapeutics.

This week's round-up of pharma licensing deals features alliances involving Tenaya Therapeutics, Sino Bio, Antengene, and A2A ...

What if the thermal noise that hinders the efficiency of both classical and quantum computers could, instead, be used as a ...

Agreement Combines Tenaya’s Expertise in Identification and Validation ofGenetic Heart Disease Targets with Alnylam’s Ability to Deliver Transformational Therapeutics Tenaya to Receive Up to $10 ...

Market Outlook and Growth TrajectoryThe global next generation sequencing market is poised to experience robust expansion, registering an estimated growth rate of around 15% over the next five years.

Researchers from Duke Health and the University of Minnesota recently discovered that measuring specific tiny genetic ...

AI in genomics offers transformative opportunities by enhancing drug discovery and personalized medicine through efficient genomic data analysis. Drivers include the surge in genomic data, the focus ...

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or only MSI-positive tumors, accuracy fell substantially, revealing that the ...

Artificial Intelligence (AI) is rapidly reshaping the healthcare industry. What once seemed like science fiction is now becoming a daily reality ...

Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, ...